Refractory Melanoma
Oncology·MeSH: Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
Frequently asked questions
How many drugs are in development for Refractory Melanoma?
BioSniper tracks 1 drug in development for Refractory Melanoma across 1 company.
How many clinical trials target Refractory Melanoma?
There are 2 clinical trials targeting Refractory Melanoma tracked by BioSniper.
What is the prevalence of Refractory Melanoma?
The estimated prevalence of Refractory Melanoma is approximately 75.0 per 100,000 population.
Deep-dive into Refractory Melanoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis